An ancient gene variant, a modern diet debate, and 870 grams of meat per week

Karolinska Institutet / JAMA Network Open

The APOE4 gene variant is an evolutionary relic. It is the oldest form of the APOE gene, likely shaped during a period when early humans ate diets rich in animal protein and fat. Today, it is best known for something else entirely: carrying one copy of APOE4 roughly triples the risk of Alzheimer's disease. Two copies can increase it tenfold.

Jakob Norgren, a researcher at Karolinska Institutet in Stockholm, wanted to test an idea that follows logically from that evolutionary history. If APOE4 evolved in the context of a meat-heavy diet, might its carriers still metabolize animal foods differently? And could that difference affect their risk of cognitive decline?

The answer, from a 15-year study of more than 2,100 older Swedish adults, is a qualified yes.

The SNAC-K cohort and 15 years of follow-up

The data came from the Swedish National Study on Aging and Care, Kungsholmen (SNAC-K), a well-established cohort based in central Stockholm. All participants were aged 60 or older and free of dementia at enrollment. Researchers tracked self-reported dietary intake, administered regular cognitive assessments, and monitored dementia diagnoses over up to 15 years, adjusting for age, sex, education, and lifestyle factors.

About 30% of the Swedish population carries one or two copies of the APOE4 variant (genotypes APOE 3/4 or 4/4). In the SNAC-K cohort, this subgroup showed the expected pattern at lower levels of meat consumption: their risk of dementia was more than twice that of people with other APOE variants.

But among the top fifth of meat consumers — those eating a median of approximately 870 grams per week, standardized to 2,000 daily calories — the elevated risk vanished. The APOE4 carriers in this group showed cognitive trajectories indistinguishable from non-carriers.

Not all meat is equal

The study drew a sharp line between processed and unprocessed meat. A lower proportion of processed meat in total consumption was associated with reduced dementia risk across all APOE genotypes, not just among risk carriers. Processed meat — bacon, sausages, deli meats — offered no cognitive protection regardless of genetic background.

Unprocessed meat told a different story. In a follow-up analysis, APOE 3/4 and 4/4 carriers who ate more unprocessed meat also showed significantly lower all-cause mortality. The protective association, whatever drives it, appeared to extend beyond the brain.

"A lower proportion of processed meat in total meat consumption was associated with a lower risk of dementia regardless of APOE genotype," said Sara Garcia-Ptacek, assistant professor at Karolinska Institutet and a senior author of the study.

A challenge to one-size-fits-all dietary advice

Dietary guidelines in most Western countries recommend limiting red meat consumption. Those recommendations are driven primarily by cardiovascular and cancer risk data and do not account for genetic variation in how individuals metabolize dietary components.

Norgren was candid about the tension: "There is a lack of dietary research into brain health, and our findings suggest that conventional dietary advice may be unfavourable to a genetically defined subgroup of the population."

He also pointed to a geographic wrinkle. APOE4 prevalence is roughly twice as high in Nordic countries as in Mediterranean populations. The Mediterranean diet — high in fish, olive oil, vegetables, and low in red meat — has become a default recommendation for brain health, partly based on studies in populations where APOE4 is less common. Whether that dietary pattern serves Nordic APOE4 carriers equally well is an open question this study complicates.

"Since the prevalence of APOE4 is about twice as high in the Nordic countries as in the Mediterranean countries, we are particularly well suited to conduct research on tailored dietary recommendations for this risk group," Norgren said.

Correlation, not prescription

The study is observational. It cannot prove that eating meat protected APOE4 carriers from cognitive decline. Several alternative explanations remain plausible.

People who eat more meat may consume more protein, iron, zinc, and B vitamins overall. They may have higher caloric intake, which in elderly populations can itself be protective against frailty and cognitive decline. They may differ in socioeconomic status, social engagement, or other lifestyle factors that the statistical adjustments did not fully capture. Self-reported dietary data — collected via food frequency questionnaires — is imprecise, and dietary patterns at enrollment may not reflect lifelong habits.

The cohort was also drawn from a single urban area in Stockholm, was exclusively Swedish, and was elderly. Younger populations, other ethnicities, and different dietary cultures may show different patterns.

The mechanism remains unclear. APOE4 affects cholesterol transport in the brain and bloodstream, and animal-derived nutrients may interact with these pathways in genotype-specific ways, but that is speculation based on the observational data, not a demonstrated mechanism.

"Clinical trials are now needed to develop dietary recommendations tailored to APOE genotype," Norgren said. For now, the study offers a provocation more than a prescription: the possibility that genetic background should inform dietary advice, and that what harms one person's brain may help another's.